These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19707954)

  • 1. Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.
    Hori H; Ueda N; Yoshimura R; Yamamoto H; Wani K; Etoh Y; Haraga K; Kitahara J; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 3):741-5. PubMed ID: 19707954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.
    Kinon BJ; Hill AL; Liu H; Kollack-Walker S
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):97-102. PubMed ID: 12890301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.
    Pascual JC; Pérez V; Martín JL; Safont G; Puigdemont D; Alvarez E
    Actas Esp Psiquiatr; 2007; 35(1):47-51. PubMed ID: 17323225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
    Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
    World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
    Lecrubier Y; Quintin P; Bouhassira M; Perrin E; Lancrenon S
    Acta Psychiatr Scand; 2006 Nov; 114(5):319-27. PubMed ID: 17022791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine orally disintegrating tablet: a review of efficacy and compliance.
    San L; Casillas M; Ciudad A; Gilaberte I
    CNS Neurosci Ther; 2008; 14(3):203-14. PubMed ID: 18801113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
    Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
    Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine optimal dose: results of an open-label multicenter study in schizophrenic patients. Olanzapine Late-Phase II Study Group.
    Ishigooka J; Murasaki M; Miura S
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):467-78. PubMed ID: 10997865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.
    Pivac N; Kozaric-Kovacic D; Muck-Seler D
    Psychopharmacology (Berl); 2004 Oct; 175(4):451-6. PubMed ID: 15064916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders.
    Turczyński J; Bidzan L; Staszewska-Małys E
    Med Sci Monit; 2004 May; 10(5):PI74-80. PubMed ID: 15114282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
    Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
    J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study].
    Escobar R; San L; Pérez V; Olivares JM; Polavieja P; López-Carrero C; Casillas M; Montoya A
    Actas Esp Psiquiatr; 2008; 36(3):151-7. PubMed ID: 18478455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.